Avantor Shorts Keep Unwinding After Earnings

AVTR is the quieter name in a sector week where peers moved sharply in both directions, but its short interest story has become harder to ignore.

Among its closest correlated names, CRL gained nearly 14% on the week and MEDP added more than 8%. WAT rose 5.8%. Avantor's 3.1% weekly gain sits right at the peer median, making it neither standout nor laggard on price. What separates it is what short sellers have been doing. Short interest has dropped to 4.96% of free float, roughly 33.8 million shares, down nearly 18% on the week and 31% over the past month. That is 1.8 standard deviations below Avantor's typical weekly move, a pace of short-covering that stands out even against a month that already saw significant reduction. The earlier note published on October 25 described a drop from around 49 million shares to 39 million in early October. That unwind has since continued, taking positions to their lowest level in the observed history. Borrow conditions remain entirely permissive: availability is above 4,600%, meaning shares available to borrow are roughly 46 times the existing short position, and the cost to borrow is 0.36%, among the lowest readings of the past six weeks. Shorts are leaving not because the borrow is expensive or tight, but because views are changing.

Options positioning has grown modestly more cautious as the stock approaches its Thursday earnings release. The put/call ratio is 0.33, above its 20-day average of 0.21, though at just 0.57 standard deviations above that mean the shift is notable rather than extreme. The 52-week range on the PCR runs from 0.04 to 12.74, so the current reading sits well toward the calm end of that scale. Retail attention, measured by Wikipedia page traffic, is running with a z-score of 1.95 relative to the company's own 90-day history, the highest in recent weeks, consistent with pre-earnings interest rather than a structural shift in sentiment. The ORTEX short score has eased to 39.8 from 44.2 a week ago, moving in the direction that typically reflects diminishing short-side conviction.

The Street remains cautious but has been nudging targets higher ahead of the print. Consensus sits at Hold, with a mean price target of $15.50 against the current price of $17.13. That gap between price and target is the more interesting data point: the stock has run past where most analysts told clients to expect it, with Morgan Stanley and TD Cowen both raising targets in mid-October to $15 and $17 respectively, still maintaining neutral ratings. Barclays lifted its Underweight target to $15. The direction of travel across the covering analysts is upward revision, but no firm has moved to a positive rating. The bull case centres on the VWR segment returning to positive organic growth and management's Revival programme appearing to drive durable improvement. Bears point to structural share losses against Thermo Fisher, margins that have dropped to the low-teens, and free cash flow that looked stretched at $39 million in the first quarter against full-year guidance of $500 million to $550 million. The EV/EBITDA multiple is 15x, which has compressed slightly over the past week and month. The earnings yield factor ranks in the 78th percentile.

Dodge and Cox remains the dominant holder at 17.7% of shares, having grown its position materially over the past year. BlackRock added 4.6 million shares in the quarter to September. Dimensional Fund Advisors added 3.5 million shares in the same period and Invesco added 6.2 million. T. Rowe Price, by contrast, has reduced its disclosed stake from 8.3% to 4.8% across filings, falling below the 5% threshold. All 13D/G positions are as last disclosed and holders dropping below 5% may not file again.

The earnings event on Thursday is the level that resets everything. The only prior data point in the history is a 1-day move of negative 1.4% after the July print, with a 5-day drift of negative 1.9%. What changes the picture on the short interest story is whether covering continues after the print, or whether sellers who have been exiting find a reason to rebuild at the current price level.